1-4 of 4
Edward Arrowsmith, MD, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial Evaluating the Safety of Rapid Infusion Ofatumumab (OFA) in Patients (pts) with Previously Treated Chronic Lymphocytic Leukemia (CLL)

William B. Donnellan, MD, Jesus Berdeja, MD, Dianna Shipley, MD, Edward Arrowsmith, MD MPH, David Wright, MD, Scott Lunin, MD, Richard H. Brown, MD, James Essell, MD, Ian Flinn
Journal: Blood
Blood (2014) 124 (21): 3336.
https://doi.org/10.1182/blood.V124.21.3336.3336
Published: 2014
Journal Articles

A Single-Arm, Open-Label, Multi-Center Phase I/II Study Of The Combination Of Panobinostat and Carfilzomib In Patients (pts) With Relapsed Or Relapse/Refractory Multiple Myeloma (MM)

Jesus Berdeja, MD, Michael Savona, MD, Joseph R Mace, MD, Lowell Hart, MD, James Essell, MD, Rami Owera, MD, Edward Arrowsmith, MD, MPH, Ian Flinn, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1937.
https://doi.org/10.1182/blood.V122.21.1937.1937
Published: 2013
Journal Articles

Rituximab, Lenalidomide, and Bortezomib in the First-Line or Second-Line Treatment of Patients with Mantle Cell Lymphoma a Phase I/II Trial.

Ian W. Flinn, MD, PhD, Mark Mainwaring, MD, PhD, Nancy Peacock, MD, Dianna Shipley, MD, Edward Arrowsmith, MD, MPH, Michael R. Savona, MD, FACP, John D. Hainsworth, MD, Jesus G. Berdeja, MD
Journal: Blood
Blood (2012) 120 (21): 2748.
https://doi.org/10.1182/blood.V120.21.2748.2748
Published: 2012
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment of Patients with Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy: Toxicity Comparison of Two Dose Schedules

Jesus G. Berdeja, MD, Michael R. Savona, MD, FACP, James Essell, MD, Patrick Murphy, MD, Luis Chu, MD, Ralph V. Boccia, MD, Edward Arrowsmith, MD, MPH, Ian W. Flinn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4047.
https://doi.org/10.1182/blood.V120.21.4047.4047
Published: 2012